Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M205621200 on July 8, 2002

J. Biol. Chem., Vol. 277, Issue 37, 34161-34167, September 13, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/37/34161    most recent
M205621200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meyer, A.
Right arrow Articles by Witholt, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meyer, A.
Right arrow Articles by Witholt, B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Hydroxylation of Indole by Laboratory-evolved 2-Hydroxybiphenyl 3-Monooxygenase*

Andreas MeyerDagger , Michael WürstenDagger , Andreas SchmidDagger , Hans-Peter E. Kohler§, and Bernard WitholtDagger

From the Dagger  Institute of Biotechnology, Swiss Federal Institute of Technology (ETH) Zurich, ETH Hönggerberg-HPT, CH-8093 Zürich, Switzerland and § Environmental Microbiology and Molecular Ecotoxicology, Swiss Federal Institute of Environmental Sciences and Technology, CH-8600 Dübendorf, Switzerland

Received for publication, June 6, 2002, and in revised form, June 27, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Directed enzyme evolution of 2-hydroxybiphenyl 3-monooxygenase (HbpA; EC 1.14.13.44) from Pseudomonas azelaica HBP1 resulted in an enzyme variant (HbpAind) that hydroxylates indole and indole derivatives such as hydroxyindoles and 5-bromoindole. The wild-type protein does not catalyze these reactions. HbpAind contains amino acid substitutions D222V and V368A. The activity for indole hydroxylation was increased 18-fold in this variant. Concomitantly, the Kd value for indole decreased from 1.5 mM to 78 µM. Investigation of the major reaction products of HbpAind with indole revealed hydroxylation at the carbons of the pyrrole ring of the substrate. Subsequent enzyme-independent condensation and oxidation of the reaction products led to the formation of indigo and indirubin. The activity of the HbpAind mutant monooxygenase for the natural substrate 2-hydroxybiphenyl was six times lower than that of the wild-type enzyme. In HbpAind, there was significantly increased uncoupling of NADH oxidation from 2-hydroxybiphenyl hydroxylation, which could be attributed to the substitution D222V. The position of Asp222 in HbpA, the chemical properties of this residue, and the effects of its substitution indicate that Asp222 is involved in substrate activation in HbpA.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Indole is produced from the aromatic amino acid tryptophan in tryptophanase-synthesizing bacteria such as Escherichia coli (1). Enzymes that oxygenate the indole pyrrole ring are easily detectable because the reaction products are unstable and form pigments. This observation was first made when the naphthalene oxidation genes were expressed in E. coli, which resulted in the biosynthesis of indigo (2). Based on these results and because of its importance as a dye, the biocatalytic production of indigo by naphthalene dioxygenase was for some time a major goal of the biotech industry (3, 4).

Naphthalene dioxygenase was soon found not to be the only enzyme capable of indole oxidation: several other oxygenases that accept indole as a substrate have been identified (5-10). These are either enzymes similar to naphthalene dioxygenase that activate oxygen with iron centers or members of the cytochrome P450 family (6, 11). Although flavin nucleotides may be involved in electron transfer from cofactors in these proteins, none is known to be a flavoprotein oxygenase.

This situation has changed with our recent finding that flavosystem oxygenases can be modified to accept unnatural substrates. 2-Hydroxybiphenyl 3-monooxygenase (HbpA; EC 1.14.13.44) from Pseudomonas azelaica HBP1 is a flavoprotein aromatic hydroxylase that catalyzes the hydroxylation of a variety of 2-substituted phenols to the corresponding catechols (12-14). The mechanism of HbpA has been extensively studied by spectroscopic techniques, which revealed that molecular oxygen is activated via the formation of a flavin (C4a)-hydroperoxide (15), a common intermediate in the reaction cycle of this enzyme family (16). HbpA has a broad substrate spectrum, but does not hydroxylate indole (13, 17). By directed enzyme evolution, we recently changed the substrate reactivity of HbpA toward 2-tert-butylphenol, a substrate that is not converted by the wild-type enzyme (18, 19). As a side product of this work, we also obtained an HbpA variant (which we denoted HbpAind) with activity for the hydroxylation of indole.

In this study, we report the characterization of HbpAind with respect to its catalytic properties. Whereas previous work on indole-oxygenating enzymes was mainly aimed at the biotechnological production of indigo, we were especially interested in the formation of the by-product indirubin. Indirubin and its analogs have been identified as potent inhibitors of cyclin-dependent kinases (20). The crystal structure of cyclin-dependent kinase-2 in complex with indirubin derivatives showed that indirubin binds to the kinase ATP-binding site. As a consequence, it inhibits the proliferation of a wide range of cells and belongs to a group of novel anticancer compounds that act on the cell cycle (21).

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Chemicals, Strains, and Plasmids

Escherichia coli JM101 (22) and the pUC18 plasmid (23) were used throughout for cloning and expression of the hbpA gene. Alkaline phosphatase (EC 3.1.3.1) was purchased from Roche Molecular Biochemicals (Basel, Switzerland). Catalase (EC 1.11.1.6) from beef liver and formate dehydrogenase (EC 1.2.1.2) from Candida boidinii were obtained from Fluka AG (Buchs, Switzerland). 4- and 5-hydroxyindole were from ICN Biomedicals Inc. (Aurora, OH). Components for the complex medium were obtained from Difco. All other chemicals were of the purest available quality and obtained from Fluka AG.

Directed Evolution of HbpA

Directed evolution of HbpA was performed by error-prone PCR based on in vitro manganese mutagenesis as described earlier (18). The mutant library was subsequently plated onto LB medium. Cells harboring enzymes with activity for the hydroxylation of indole formed deep blue colonies. The single mutant D222V (HbpAD222V) was constructed using the QuickChangeTM site-directed mutagenesis kit from Stratagene (La Jolla, CA).

Protein Synthesis and Purification

Synthesis of wild-type HbpA and HbpAind was done in recombinant E. coli JM101 using M9 mineral medium and glycerol as the carbon source (17). After harvesting the cells, the proteins were purified according to the method described recently (18).

Analytical Methods

Determination of Activity for 2-Hydroxybiphenyl-- The activity of wild-type HbpA and HbpAind was determined by measuring substrate consumption and product formation with reverse-phase high pressure liquid chromatography (HPLC)1 as described elsewhere (24). The assay contained 0.2 µM HbpA or variant protein, 0.3 mM NADH, 0.2 mM 2-hydroxybiphenyl, and 20 mM air-saturated phosphate buffer (pH 7.5).

Determination of in Vivo Indigo Formation-- The activity of recombinant E. coli JM101 for the formation of indigo was determined in 250-ml shaking flasks containing 50 ml of LB medium (22). Cultures of E. coli JM101 cells harboring a pUC18 derivative encoding HbpA or HbpAind were inoculated to A450 = 0.1. The cultures were incubated at 30 °C and vigorously shaken. When the culture color turned olive, samples of 1.1 ml were taken. 100 µl of these were used to determine the cell dry weight at 450 nm (25). The remaining 1 ml was centrifuged, and the supernatant was carefully removed. Cell-associated indigo was extracted with N,N-dimethylformamide (DMF) and quantified at 610 nm (epsilon 610 = 15,900 liters mol-1 cm-1) (8).

Determination of in Vitro Indigo Formation-- The activity for indole was determined using an assay with NADH regeneration by formate dehydrogenase from C. boidinii (Fig. 1) (26). The assay contained 0.2 µM HbpA or variant, 0.25 units of formate dehydrogenase, 160 mM sodium formate, 10 units of catalase from beef liver, 0.3 mM NADH, and 2 mM indole in 1 ml of 50 mM sodium phosphate buffer (pH 7.5). The assay was stopped by the addition of 20 µl of 10% (v/v) perchloric acid, and the precipitated proteins were spun down. The pellet- and tube-associated indigo was extracted with DMF and spectrophotometrically quantified.


View larger version (9K):
[in this window]
[in a new window]
 
Fig. 1.   Scheme of in vitro indigo formation assay. HbpA, 2-hydroxybiphenyl 3-monooxygenase or HbpAind; FDH, formate dehydrogenase.

Determination of Dissociation Constants-- Dissociation constants between the enzymes and substrates were determined by monitoring the absorption changes of the enzyme-bound FAD upon binding of substrate (27). For this, 12 µM purified wild-type HbpA and HbpAind were titrated with known concentrations of 2-hydroxybiphenyl or indole, and the resulting spectra were recorded using a Varian Cary E1 UV-visible spectrophotometer. Plotting Delta  absorbance at a specific wavelength allowed the calculation of the dissociation constants by weighted nonlinear regression analysis (Enzfitter, Elsevier-Biosoft, Cambridge, U. K.).

HPLC-Mass Spectroscopy (MS) Analysis-- Analysis of compounds formed during in vitro indigo assays was done by reverse-phase HPLC-MS (Hewlett Packard 1100 MSD). The compounds were separated on a Hypersil ODS column (5 µm, 4.5 × 125 mm) and detected with a diode array detector and a mass spectrometer. Acidified (0.1% formic acid) H2O (solvent A) and 50% methanol and 50% acetonitrile (solvent B) were applied as the mobile phase according to the following timetable: 0 to 8 min, 85:15 solvent A/solvent B, flow rate of 1 ml min-1; gradient to 10 min, to 65:35 solvent A/solvent B, flow rate of 2 ml min-1; to 15 min, 65:35 solvent A/solvent B, flow rate of 2 ml min-1. Standards for isatin, 4- and 5-hydroxyindole, 2-indolinone, and indole were commercially available. 3-Indoxyl was prepared by dephosphorylating 3-indoxyl phosphate with alkaline phosphatase under anaerobic conditions. HPLC-MS analysis of the formed pigments was done under isocratic conditions at a flow rate of 1 ml min-1 with 70% (v/v) methanol as the mobile phase for the pigments derived from indole and with 40% (v/v) methanol for those derived from 4- and 5-hydroxyindole.

TLC Analysis-- The formed pigments were analyzed by TLC using silica gel cards and either toluene/acetone (4:1) or chloroform/acetone (97:3) as the mobile phase (28).

Electron Microscopy-- For ultrathin sectioning, cells were fixed in 2.5% glutaraldehyde for 60 min and subsequently washed with water and embedded in low-melting-point agarose. After fixation in 1% OsO4 for 60 min, the blocks were dehydrated with ethanol and acetone and embedded in Epon/Araldite (29). Sections cut from the Epon/Araldite preparation were contrasted with uranyl acetate and lead citrate.

Freeze-fracturing was carried out following standard procedures using a Balzers BAF 300 apparatus. The specimen sandwiches were fractured at -150 °C and immediately replicated with platinum/carbon. All pictures were taken with a Philips EM301 electron microscope.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Directed Evolution of HbpA

We recently changed the substrate reactivity of 2-hydroxybiphenyl 3-monooxygenase (HbpA) from P. azelaica HBP1 by directed evolution (18). This work led to a mutant monooxygenase with increased activity for the hydroxylation of indole. The HbpA variant was denoted HbpAind. E. coli JM101 cultures synthesizing HbpAind turned deep blue when grown overnight on LB medium. Electron microscopy revealed the extracellular accumulation of material, which, we believe, consists of the water-insoluble pigment. After centrifugation, the pigment was extracted from the pellet with DMF. It was authenticated as indigo by TLC with toluene/acetone (4:1) as the mobile phase and commercially available indigo as the standard. This analysis also revealed the presence of a major by-product. The RF value of this red pigment corresponded to the RF value determined earlier for indirubin (28). Analysis by HPLC-MS with 70% (v/v) methanol as the mobile phase showed two prominent molecular ion (MH+) peaks at m/z 263 with retention times of 3.7 and 4.2 min. The UV-visible spectra and the fragmentation patterns were compared with literature data (28, 30, 31), which confirmed that these two compounds were indigo (3.7 min) and indirubin (4.2 min).

The formation of indigo by recombinant E. coli JM101 cells growing on LB medium was quantified. Cultures expressing the hbpAind gene accumulated 150 µM indigo within 8 h, whereas cultures of the host synthesizing HbpA remained colorless (Fig. 2). Recombinant protein levels in both cultures were checked by SDS-PAGE, and HbpA levels were determined to be in the same range of ~20% of total cell protein.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 2.   In vivo indigo formation by HbpA and HbpAind. Shown is the formation of indigo during growth of recombinant E. coli JM101 cells on LB medium synthesizing wild-type HbpA or HbpAind. Symbols for cell dry weight (CDW) are as follows: , wild-type HbpA; and open circle , HbpAind. Symbols for indigo concentration are as follows: black-square, wild-type HbpA; and , HbpAind.

Stability of Biotechnologically Produced Indigo

When pigments were extracted with DMF from recombinant E. coli JM101 cultures, the extract had a deep blue color. The blue color disappeared upon storage at room temperature, and the solution turned red (Fig. 3). The red pigment was analyzed by UV-visible spectroscopy, HPLC-MS, and TLC. It was authenticated as indirubin by comparison of the obtained results with literature data (28, 30, 31). Buffering the pH at a value of 7 or acidification with 0.1% (v/v) 10 M hydrochloric acid stabilized the formed indigo, whereas the addition of 0.1% (v/v) 10 M sodium hydroxide or heating accelerated the disappearance of the blue color.


View larger version (65K):
[in this window]
[in a new window]
 
Fig. 3.   Indigo and indirubin. Shown is indigo freshly extracted from a recombinant E. coli culture (right) and after incubation at room temperature for 72 h (left).

General Properties of HbpAind

The mutant monooxygenase HbpAind differs from wild-type HbpA by two amino acids: Asp222 was substituted by valine, and Val368 was substituted by alanine. HbpAind was purified according to the procedure developed for the wild-type enzyme with a yield of ~30%. Analytical size-exclusion chromatography showed that the mutant monooxygenase formed a tetramer, which is also the case for wild-type HbpA (14).

Major Reaction Products of Indole Hydroxylation by HbpAind

To identify the major reaction products of indole hydroxylation, in vitro indigo formation assays were performed. After 30 min, a sample was taken and immediately saturated with argon. The proteins were precipitated and separated by centrifugation. The pigments in the pellet were extracted with DMF and analyzed by TLC. They were identified as indigo and indirubin. Analysis of the aqueous phase by HPLC-MS revealed the presence of 3-hydroxyindole (indoxyl) and 2-indolinone (oxindole). When a sample was taken after 60 min of assay time, isatin was also detected (Table I).

                              
View this table:
[in this window]
[in a new window]
 
Table I
Major reaction products of indole hydroxylation by HbpAind
The major reaction products of in vitro indole assays were authenticated by reverse-phase HPLC-MS. The assays contained 0.2 µM HbpAind, 0.25 units of formate dehydrogenase, 160 mM sodium formate, 10 units of catalase, 0.3 mM NADH, and 2 mM indole in 1 ml of 50 mM sodium phosphate buffer (pH 7.5).

Substrate Spectrum of HbpAind

To investigate the substrate range of the HbpAind mutant monooxygenase, in vitro assays were performed with 4- and 5-hydroxyindole and 5-bromoindole. For the variant enzyme, color formation could be observed with all substrates, whereas the control assays with the wild-type protein remained colorless. The pigment derived from 4-hydroxyindole was purple, that from 5-hydroxyindole was orange, and that from 5-bromoindole was pink.

The polar reaction products of the assays with 4- and 5-hydroxyindole were analyzed by HPLC-MS. For this, the in vitro assay was stopped by the addition of perchloric acid, and the proteins were spun down. Mass peaks (MH+) at m/z 150 were detected in the supernatants from both reactions. This mass correlates with the single hydroxylated substrates. The corresponding compounds eluted between 4.5 and 6.5 min when using 40% (v/v) methanol as the mobile phase. The main condensation products had a prominent molecular ion peak (MH+) at m/z 279 and had retention times of 4.1 min for the assay with 4-hydroxyindole and 3.5 min for the assay with the 5-substituted isomer. UV-visible spectra showed the peak at 4.1 min to have a maximum at 494 nm, whereas the peak at 3.5 min had a maximum at 480 nm. Thus, the molecular mass and the spectral properties indicated that the dihydroxy derivatives of indoxyl red were formed (see Fig. 7).

Catalytic Properties of HbpA and HbpAind

Specific Activities for 2-Hydroxybiphenyl and Indole-- The in vitro activity of the purified proteins for the natural substrate 2-hydroxybiphenyl was determined by measuring substrate consumption and product formation by reverse-phase HPLC. The kcat of HbpAind was significantly lower than that of the wild-type enzyme (Table II). Indole hydroxylation activities were determined in assays with purified proteins and NADH regeneration by formate dehydrogenase from C. boidinii. The assay mixture containing the mutant monooxygenase showed a blue color within the first 30 min, whereas the assay mixture with the wild-type enzyme remained white. HbpAind formed up to 170 µM indigo, whereas hardly any indigo formation could be observed for HbpA (Fig. 4). The indole hydroxylation activity of HbpAind was ~20 milliunits mg-1 purified protein or ~18 times higher than the corresponding value for the wild-type enzyme.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Kd and kcat values of wild-type HbpA and HbpAind for 2-hydroxybiphenyl and indole


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 4.   In vitro indigo formation by HbpA and HbpAind. The assay contained 0.2 µM HbpA or HbpAind, 0.25 units of formate dehydrogenase, 160 mM sodium formate, 10 units of catalase, 0.3 mM NADH, and 2 mM indole in 1 ml of 50 mM sodium phosphate buffer (pH 7.5). Indigo formation was determined at 610 nm. open circle , wild-type HbpA; black-square, HbpAind.

Equilibrium Binding of Substrates to HbpA and HbpAind-- The affinities of the enzymes for 2-hydroxybiphenyl and indole were determined by titration of the purified proteins with known concentrations of substrate (Fig. 5, insets). Plotting the absorption difference at a specific wavelength as a function of substrate concentration (Fig. 5) allowed the determination of the Kd values. Whereas the dissociation constants for 2-hydroxybiphenyl were in the same range for both proteins, the Kd value for indole was 20-fold lower for HbpAind than for HbpA (Table II).


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 5.   Equilibrium binding of indole to wild-type HbpA and HbpAind. A, absorption changes at 490 nm during titration of 12 µM wild-type HbpA with 0.3, 0.7, 1.3, 2.3, 4, and 6.7 mM indole. The inset shows the difference spectra in the presence of 0.3, 0.7, and 2.3 mM substrate. B, absorption changes at 495 nm during titration of 12 µM HbpAind with 33.3, 66.7, 100, 166.7, 266.7, 433.3, and 666.7 µM indole. The inset shows the difference spectra in the presence of 33.3, 66.7, and 100 µM substrate.

Uncoupling of NADH Oxidation from 2-Hydroxybiphenyl Hydroxylation-- Wild-type HbpA shows an uncoupling of NADH oxidation from 2-hydroxybiphenyl hydroxylation of 21% (18). Substitution of a single amino acid (V368A in HbpAT1) completely coupled these two reactions (18). In contrast, there was significant uncoupling of NADH oxidation from hydroxylation for HbpAind compared with HbpA and HbpAT1 (Table III). To investigate whether the increased uncoupling in HbpAind is an effect of the combination of the two amino acid substitutions or only due to the D222V exchange, the single mutant D222V (HbpAD222V) was constructed by site-directed mutagenesis. Uncoupling of NADH oxidation from 2-hydroxybiphenyl hydroxylation was 3-fold higher for the HbpAD222V mutant monooxygenase than for the wild-type protein (Table III).

                              
View this table:
[in this window]
[in a new window]
 
Table III
Uncoupling of NADH oxidation from 2-hydroxybiphenyl hydroxylation
The assays were performed at 30 °C in 20 mM sodium phosphate buffer (pH 7.5) containing 0.3 mM NADH and 0.2 mM 2-hydroxybiphenyl.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Hydroxylation of Indole by HbpAind-- Indole is oxidized by different oxygenases that contain either protein-bound iron or cytochrome to activate molecular oxygen (6, 32). No flavoprotein oxygenase has thus far been shown to accept indole as a substrate. A 2-hydroxybiphenyl 3-monooxygenase variant (HbpAind), which we obtained during directed evolution of HbpA, showed the ability to hydroxylate indole. The kcat/Kd of HbpAind for indole was 330-fold higher than that of wild-type HbpA and is in the same order as the catalytic efficiency determined for the engineered fatty-acid hydroxylase P450 BM-3 (33). This P450 variant was obtained by saturation mutagenesis and is the enzyme with the highest known catalytic efficiency for indole.

Cultures of E. coli JM101 cells that synthesized HbpAind during growth on LB medium had an indigo productivity of ~5 mg liter-1 h-1. In comparison, a recombinant E. coli HB101 culture that expressed the naphthalene dioxygenase genes produced ~1 mg liter-1 h-1 during growth on the same medium to a similar cell density (2). E. coli cultures that synthesized human P450 cytochromes reached productivities of ~0.3 mg liter-1 h-1 on fortified terrific broth (TB) medium (6). Thus, the HbpAind flavoprotein recombinant is considerably (5-15-fold) more active in vivo in the formation of indigo from complex medium. Analysis of the pigments formed also showed the presence of the by-product indirubin, a structural isomer of indigo that is known to be formed by indole-oxidizing enzymes (4, 10).

Indigo extracted from recombinant E. coli cultures showed only limited stability when stored in DMF at room temperature. This could be attributed to the pH of the solution. It is known from denim manufacturing that at basic pH indigo is chemically reduced to its water-soluble form, indigo white. In contrast, the formed indirubin was stable when extracted and stored in DMF.

Major Reaction Products of Indole Hydroxylation-- The products of indole oxidation by different mono- and dioxygenases have been investigated. Indole epoxide has been suggested as a product of the reaction catalyzed by styrene monooxygenase (7), and indoxyl (3-hydroxyindole) has been identified as a hydroxylation product of cytochrome P450 enzymes (6). Oxidation by naphthalene dioxygenase results in the formation of 2,3-dihydroxy-2,3-dihydroindole (2). All these reaction products are unstable and spontaneously form pigments. The identification of the intermediates formed during in vitro indigo assays with HbpAind suggests a similar route as observed for the P450 enzymes (Fig. 6). The identification of 3-hydroxyindole and 2-indolinone indicates direct hydroxylation at the carbons of the pyrrole ring of indole. In contrast to the P450 enzymes, no hydroxylation at the benzene ring of the substrate was observed (6). The presence of isatin could have two origins: it was produced either by hydroxylation of indoxyl or oxindole or by the decomposition of indigo and indirubin. The formation of indigo and indirubin from the enzymatic hydroxylation products of indole is spontaneous and biocatalyst-independent. In short, condensation of two molecules of indoxyl followed by air oxidation leads to the production of indigo, whereas condensation of indoxyl and 2-indolinone yields indirubin (28, 34). In addition, indirubin can also be formed by the reaction of indoxyl with isatin (4, 35). That this latter reaction does indeed take place in the case of indirubin formation by HbpAind is supported by the fact that the ratio of indirubin to indigo increased with time when recombinant E. coli cells were grown on LB medium.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 6.   Proposed pathway for the formation of indigo and indirubin by HbpAind. 1, indole; 2, 3-hydroxyindole (indoxyl); 2a, 3-indolinone; 3, 2-hydroxyindole; 3a, 2-indolinone (oxindole); 4, isatin; 5, indirubin; 6, indigo.

Substrate Spectrum of HbpAind-- Indirubin inhibits cyclin-dependent kinases and therefore belongs to a group of promising anticancer compounds (20). Analogs such as indirubin 3'-monoxime and halogenated indirubins show even higher potency (36). This increased biological activity can be attributed to the lower hydrophobicity of the derivatives compared to indirubin. Thus, the uptake of the compound is facilitated and the probability that it reaches the biological sites of action is increased (37). In this context, we investigated the substrate spectrum of HbpAind. The variant showed activity with several indole derivatives such as 4- and 5-hydroxyindole. The products of these reactions are potentially interesting because their log P values are significantly different from that of the unsubstituted indirubin and are hardly accessible by chemical means. However, analysis of the formed pigments showed that the dihydroxyindirubin derivatives were only a minor product of the reaction of HbpAind with hydroxyindoles. The mass and the spectral properties of the major condensation product indicated that mainly the indoxyl red derivatives were formed. Indoxyl red is known to be formed from the reaction of 3-oxo-3H-indole with indole (38). The proposed pathway for the formation of the dihydroxy derivatives by HbpAind from hydroxyindole is shown in Fig. 7. The electron-donating hydroxyl group at the benzene ring facilitates the oxidation of the indolinone compared with the unsubstituted compound and may explain why indoxyl red was not detected from the reaction of HbpAind with indole. Indoxyl red shares a high degree of structural similarities with indirubin. The dihydroxy derivatives have a strongly decreased hydrophobicity, and their potency in inhibiting cyclin-dependent kinases is worth investigating.


View larger version (9K):
[in this window]
[in a new window]
 
Fig. 7.   Proposed pathway for the formation of dihydroxy derivatives of indoxyl red. 1, 4- or 5-hydroxyindole; 2, 4- or 5-hydroxyindoxyl; 3, 4- or 5-hydroxy-2-indolinone; 4, 4- or 5-hydroxy-3-oxo-3H-indole; 5, 4,4'- or 5,5'-dihydroxyindoxyl red.

Catalytic Properties of HbpAind-- We characterized HbpAind with respect to its catalytic properties. The variant's activity for indole was increased by ~18-fold compared with the wild-type enzyme. This increase was concomitant with an enhanced affinity of the enzyme for this substrate. The in vitro activity of the mutant monooxygenase for the natural substrate 2-hydroxybiphenyl was significantly decreased, whereas its affinity for this substrate remained unchanged. This is mostly due to a slower flavin reduction, as indicated by the reduced NADH oxidation rate. In addition, uncoupling of NADH oxidation from substrate hydroxylation was significantly increased in HbpAind. HbpAind evolved from the single mutant V368A (HbpAT1) by directed enzyme evolution. In contrast to wild-type HbpA, HbpAT1 fully couples NADH oxidation to 2-hydroxybiphenyl hydroxylation. We have suggested that this is due to the stabilization and/or improved positioning of the flavin (C4a)-hydroperoxide toward the substrate (18). This enhanced hydroxylation efficiency was completely destroyed by the D222V substitution: in HbpAind, the uncoupling was twice that of the wild-type protein with 2-hydroxybiphenyl as substrate, whereas the unproductive NADH oxidation rate was similar in both enzymes. The single mutant HbpAD222V even showed a 3-fold increased uncoupling, which was concomitant with a 3-fold increased unproductive NADH oxidation rate. Thus, the substitution D222V in HbpAind and HbpAD222V directly increased the ratio of flavin (C4a)-hydroperoxide decay to 2,3-dihydroxybiphenyl formation (Fig. 8). This ratio is primarily influenced by stabilization of the flavin (C4a)-hydroperoxide, solvent access to the active site, and the reactivity of the substrate toward electrophilic attack by the terminal oxygen of the peroxide. According to the structural model of HbpA (18), Asp222 is located close to the bound substrate in the substrate-binding domain. Interestingly, Asp222 of HbpA corresponds to Tyr201 of p-hydroxybenzoate hydroxylase from Pseudomonas fluorescens (39, 40). In p-hydroxybenzoate hydroxylase, Tyr201 is critically involved in the ionization of the substrate, thus affecting flavin movement and allowing efficient hydroxylation (41, 42). The substitution Y201F results in an increased uncoupling of NADH oxidation from substrate hydroxylation up to 95% (43). In phenol 2-monooxygenase from Trichosporon cutaneum, Tyr289 is hydrogen-bonded with the hydroxyl group of the substrate, comparable to Tyr201 in p-hydroxybenzoate hydroxylase (44). Substitution of this residue by Phe increased the uncoupling from 10 to 34% (45). With respect to the localization of Asp222 in the HbpA model, the chemical properties of this residue, and the effects resulting from its substitution, it is likely that Asp222 plays a similar role in HbpA as do the tyrosine residues in p-hydroxybenzoate hydroxylase and phenol 2-monooxygenase.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 8.   Ratio of flavin (C4a)-hydroperoxide decay to 2,3-dihydroxybiphenyl formation in the catalytic cycle of HbpA and variants. For each of the variants, the rate of formation of the flavin (C4a)-hydroperoxide was normalized compared with the wild-type enzyme, assuming flavin reduction to be the rate-limiting step (15). EFlHOOH-S, flavin (C4a)-hydroperoxide enzyme-substrate complex; EFlox, enzyme containing oxidized flavin.

In summary, we characterized the HbpAind mutant monooxygenase, the first flavoprotein able to hydroxylate indole. These investigations point to the importance of Asp222 in the catalytic cycle of HbpA. Thus, the results obtained here may serve as the basis for further elucidation of the mechanism of substrate activation in this enzyme.

    ACKNOWLEDGEMENT

We thank Dr. E. Wehrli (ETH Zurich) for performing the electron microscopy.

    FOOTNOTES

* This work was supported by Swiss National Science Foundation Grant 5002-046098.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed. Tel.: 41-1-6333286; Fax: 41-1-6331051; E-mail: bw@biotech.biol.ethz.ch.

Published, JBC Papers in Press, July 8, 2002, DOI 10.1074/jbc.M205621200

    ABBREVIATIONS

The abbreviations used are: HPLC, high pressure liquid chromatography; DMF, N,N-dimethylformamide; MS, mass spectroscopy.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. DeMoss, R. D., and Moser, K. (1969) J. Bacteriol. 98, 167-171[Abstract/Free Full Text]
2. Ensley, B. D., Ratzkin, B. J., Osslund, T. D., Simon, M. J., Wackett, L. P., and Gibson, D. T. (1983) Science 222, 167-169[Abstract/Free Full Text]
3. Murdock, D., Ensley, B. D., Serdar, C., and Thalen, M. (1993) Bio/Technology 11, 381-386
4. Bialy, H. (1997) Nat. Biotechnol. 15, 110[CrossRef][Medline] [Order article via Infotrieve]
5. Bhushan, B., Samanta, S. K., and Jain, R. K. (2000) Lett. Appl. Microbiol. 31, 5-9[CrossRef][Medline] [Order article via Infotrieve]
6. Gillam, E. M. J., Notley, L. M., Cai, H., de Voss, J. J., and Guengerich, F. P. (2000) Biochemistry 39, 13817-13824[CrossRef][Medline] [Order article via Infotrieve]
7. O'Connor, K. E., Dobson, A. D. W., and Hartmans, S. (1997) Appl. Environ. Microbiol. 63, 4287-4291[Abstract]
8. O'Connor, K. E., and Hartmans, S. (1998) Biotechnol. Lett. 20, 219-223[CrossRef]
9. Panke, S., Witholt, B., Schmid, A., and Wubbolts, M. G. (1998) Appl. Environ. Microbiol. 64, 2032-2043[Abstract/Free Full Text]
10. Hart, S., Koch, K. R., and Woods, D. R. (1992) J. Gen. Microbiol. 138, 211-216[Abstract/Free Full Text]
11. Ensley, B. D., and Gibson, D. T. (1983) J. Bacteriol. 155, 505-511[Abstract/Free Full Text]
12. Eppink, M. H. M., Schreuder, H. A., and van Berkel, W. J. H. (1997) Protein Sci. 6, 2454-2458[Medline] [Order article via Infotrieve]
13. Kohler, H.-P. E., Kohler-Staub, D., and Focht, D. D. (1988) Appl. Environ. Microbiol. 54, 2683-2688[Abstract/Free Full Text]
14. Suske, W. A., Held, M., Schmid, A., Fleischmann, T., Wubbolts, M. G., and Kohler, H.-P. E. (1997) J. Biol. Chem. 272, 24257-24265[Abstract/Free Full Text]
15. Suske, W. A., van Berkel, W. J. H., and Kohler, H.-P. E. (1999) J. Biol. Chem. 274, 33355-33365[Abstract/Free Full Text]
16. van Berkel, W. J. H., Eppink, M. H. M., van der Bolt, F. J. T., Vervoort, J., Rietjens, I. M. C. M., and Schreuder, H. A. (1997) in Flavins and Flavoproteins (Stevenson, K. J. , Massey, V. , and Williams, C. H., Jr., eds) , pp. 305-314, University of Calgary Press, Calgary, Canada
17. Held, M., Suske, W., Schmid, A., Engesser, K.-H., Kohler, H.-P. E., Witholt, B., and Wubbolts, M. G. (1998) J. Mol. Catal. B 5, 87-93
18. Meyer, A., Schmid, A., Held, M., Westphal, A. H., Röthlisberger, M., Kohler, H.-P. E., van Berkel, W. J. H., and Witholt, B. (2002) J. Biol. Chem. 277, 5575-5582[Abstract/Free Full Text]
19. Meyer, A., Held, M., Schmid, A., Kohler, H.-P. E., and Witholt, B. (2002) Biotechnol. Bioeng., in press
20. Hoessel, R., Leclerc, S., Endicott, J. A., Nobel, M. E. M., Lawrie, A., Tunnah, P., Leost, M., Damiens, E., Marie, D., Marko, D., Niederberger, E., Tang, W., Eisenbrand, G., and Meijer, L. (1999) Nat. Cell Biol. 1, 60-67[CrossRef][Medline] [Order article via Infotrieve]
21. Buolamwini, J. K. (2000) Curr. Pharm. Des. 6, 379-392[CrossRef][Medline] [Order article via Infotrieve]
22. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , 2nd Ed. , Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
23. Yanish-Perron, C., Vieira, J., and Messing, J. (1985) Gene (Amst.) 33, 103-109[CrossRef][Medline] [Order article via Infotrieve]
24. Kohler, H.-P. E., Schmid, A., and van der Maarel, M. (1993) J. Bacteriol. 175, 1621-1628[Abstract/Free Full Text]
25. Witholt, B. (1972) J. Bacteriol. 109, 350-364[Abstract/Free Full Text]
26. Kula, M.-R., and Wandrey, C. (1987) Methods Enzymol. 136, 9-21[Medline] [Order article via Infotrieve]
27. van Berkel, W., Westphal, A., Eschrich, K., Eppink, M., and de Kok, A. (1992) Eur. J. Biochem. 210, 411-419[Medline] [Order article via Infotrieve]
28. Eaton, R. W., and Chapman, P. J. (1995) J. Bacteriol. 177, 6983-6988[Abstract/Free Full Text]
29. Hess, W. M. (1966) Stain Technol. 41, 27-35[Medline] [Order article via Infotrieve]
30. Fearon, W. R., and Boggust, W. A. (1950) Biochem. J. 46, 62-67
31. Laatsch, H., and Ludwig-Köhn, H. (1986) Liebigs Ann. Chem. 1847-1853
32. Carredano, E., Karlsson, A., Kauppi, B., Choudhury, D., Parales, R. E., Parales, J. V., Lee, K., Gibson, D. T., Eklund, H., and Ramaswamy, S. (2000) J. Mol. Biol. 296, 701-712[CrossRef][Medline] [Order article via Infotrieve]
33. Li, Q.-S., Schwaneberg, U., Fischer, M., and Schmid, R. D. (2000) Chem. Eur. J. 6, 1531-1536[CrossRef]
34. Russell, G. A., and Kaupp, G. (1969) J. Am. Chem. Soc. 91, 3851-3859[CrossRef]
35. Maugard, T., Enaud, E., Choisy, P., and Legoy, M. D. (2001) Phytochemistry 58, 897-904[CrossRef][Medline] [Order article via Infotrieve]
36. Marko, D., Schatzle, S., Friedel, A., Genzlinger, A., Zankl, H., Meijer, L., and Eisenbrand, G. (2001) Br. J. Cancer 84, 283-289[CrossRef][Medline] [Order article via Infotrieve]
37. Hansch, C. (1969) Acc. Chem. Res. 2, 232-239[CrossRef]
38. Capdevielle, P., and Maumy, M. (1993) Tetrahedron Lett. 34, 2953-2956[CrossRef]
39. Gatti, D. L., Palfey, B. A., Lah, M. S., Entsch, B., Massey, V., Ballou, D. P., and Ludwig, M. L. (1994) Science 266, 110-114[Abstract/Free Full Text]
40. Schreuder, H. A., Mattevi, A., Obmolova, G., Kalk, K. H., Hol, W. G. J., van der Bolt, F. J. T., and van Berkel, W. J. H. (1994) Biochemistry 33, 10161-10170[CrossRef][Medline] [Order article via Infotrieve]
41. Palfey, B. A., Moran, G. R., Entsch, B., Ballou, D. B., and Massey, V. (1999) Biochemistry 38, 1153-1158[CrossRef][Medline] [Order article via Infotrieve]
42. Gatti, D. L., Entsch, B., Ballou, D. P., and Ludwig, M. L. (1996) Biochemistry 35, 567-578[CrossRef][Medline] [Order article via Infotrieve]
43. Entsch, B., Palfey, B. A., Ballou, D. P., and Massey, V. (1991) J. Biol. Chem. 266, 17341-17349[Abstract/Free Full Text]
44. Enroth, C., Neujahr, H., Schneider, G., and Lindqvist, Y. (1998) Structure 6, 605-617[Medline] [Order article via Infotrieve]
45. Xu, D., Ballou, D. P., and Massey, V. (2001) Biochemistry 40, 12369-12378[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Appl. Environ. Microbiol.Home page
C. Guan, J. Ju, B. R. Borlee, L. L. Williamson, B. Shen, K. F. Raffa, and J. Handelsman
Signal Mimics Derived from a Metagenomic Analysis of the Gypsy Moth Gut Microbiota
Appl. Envir. Microbiol., June 1, 2007; 73(11): 3669 - 3676.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
T. Leungsakul, G. R. Johnson, and T. K. Wood
Protein Engineering of the 4-Methyl-5-Nitrocatechol Monooxygenase from Burkholderia sp. Strain DNT for Enhanced Degradation of Nitroaromatics.
Appl. Envir. Microbiol., June 1, 2006; 72(6): 3933 - 3939.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/37/34161    most recent
M205621200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meyer, A.
Right arrow Articles by Witholt, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meyer, A.
Right arrow Articles by Witholt, B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement